CELESTENE CHRONODOSE 5.7 MG / ML
Bethamethasone
Public price
26,70 MAD
Active substance
Bethamethasone
Laboratory
MSD MAROC
Reimbursable
What is this medicine?
CELESTENE CHRONODOSE 5.7 MG / ML contains Bethamethasone. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
Bethamethasone, Solution injectable, 5.7 MG, Boîte de 1 ampoule de 1 ml
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
corticoïdes à usage systémique non associés - Princeps
Laboratory
MSD MAROC
Availability note
Reimbursable
Strength
5.7 MG
Form
Solution injectable
Presentation
Boîte de 1 ampoule de 1 ml
Type
Princeps
Therapeutic class
corticoïdes à usage systémique non associés
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 26,70 MAD
Medicines with the same active substance
CELESTENE 4 MG / ML
4 MG · Boîte de 1 ampoule de 1 ml SOLUTION INJECTABLE PAR VOIES IM, IV ET LOCALE
18,90 MAD
CELESTENE 4 MG / ML
4 MG · Solution injectable
18,90 MAD
CELESTENE 8 MG / 2 ML
8 MG / 2 ML · Boîte de 1 ampoule de 2ml
29,40 MAD
BETASTENE 0.05 %
0.05 % · Flacon de 30 ml
30,00 MAD
BETASTENE 0.05 %
30 ml · Flacon de 30 ml
30,00 MAD
CELESTENE 2 MG
2 MG · Boîte de 20
36,60 MAD
CELESTENE 2 MG
2 MG · Boîte de 20
36,60 MAD
CELESTENE 4 MG / 1 ML
4 MG / 1 ML · Boîte de 3 ampoules de 1 ml
45,80 MAD